Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VTGN - VistaGen Therapeutics Inc. (VTGN) CEO Shawn Singh on Q4 2022 Results - Earnings Call Transcript

VTGN - VistaGen Therapeutics Inc. (VTGN) CEO Shawn Singh on Q4 2022 Results - Earnings Call Transcript

VistaGen Therapeutics Inc.
VistaGen Therapeutics, Inc. (VTGN) Q4 2022 Earnings Conference Call June 23, 2022 05:00 PM ET Company Participants Mark Flather - Vice President of Investor Relations Shawn Singh - Chief Executive Officer Jerrold Dotson - Vice President, Chief Financial Officer and Secretary Mark Smith - Chief Medical Officer Conference Call Participants Andrew Tsai - Jefferies LLC Lachlan Hanbury-Brown - William Blair & Company, LLC Luke Herrmann - Robert W. Baird & Co. Michael Okunewitch - Maxim Group LLC Presentation Operator Greetings, welcome to the VistaGen Therapeutics' 2022 Fiscal Year-End Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator instructions] Please note that this conference is being recorded. I will now turn the conference over to your host, Mark Flather, Vice President of Investor Relations for VistaGen. You may begin. Mark Flather Thank you, Kyle. Hello, and welcome to

For further details see:

VistaGen Therapeutics, Inc. (VTGN) CEO Shawn Singh on Q4 2022 Results - Earnings Call Transcript
Stock Information
Company Name: VistaGen Therapeutics Inc.
Stock Symbol: VTGN
Market: NASDAQ
Website: vistagen.com
Menu
VTGN VTGN Quote VTGN Short VTGN News VTGN Articles VTGN Message Board
Get VTGN Alerts

News, Short Squeeze, Breakout and More Instantly...